Perspectives

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Is Patient Engagement in Regulatory Decisions at a Tipping Point?
To meet the challenge of meeting the growing expectation from regulators for robust patient experience data that demonstrate the impact new products may have for patients and their quality of life, our industry needs to work closely with the patient community, regulators, and other stakeholders.
View Mar 22, 2023
Unsure About the EU HTA Regulation?
Lumanity’s EU Head of Health Economics and Statistics, Suzette Matthijsse, explores the results of our EU HTA Regulation market survey.
View Feb 23, 2023
Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 3)
In part three of our series, ‘Opportunities for Enhanced Communication between Manufacturers and US Payers’, our experts explore the tools manufacturers can use to communicate HCEI to payers, insights from the Food and Drug Administration (FDA) guidance on payer communications, and practical considerations to optimize these interactions.
View Feb 6, 2023